MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2
2007

How MOZ-TIF2 Affects Gene Activity in Leukemia

publication 10 minutes Evidence: moderate

Author Information

Author(s): Yin Hong, Glass Jonathan, Blanchard Kerry L

Primary Institution: Louisiana State University Health Sciences Center

Hypothesis

The MOZ-TIF2 fusion protein affects nuclear receptor signaling and transcriptional activation.

Conclusion

MOZ-TIF2 inhibited nuclear receptor-mediated gene response by aberrant recruitment of CBP, requiring both the MOZ and TIF2 portions for this inhibition.

Supporting Evidence

  • MOZ-TIF2 expression decreased both basal and estradiol inducible reporter gene activity.
  • Stable expression of MOZ-TIF2 inhibited retinoic acid inducible gene response.
  • Deletion of the CID domain in TIF2 partially restored transcriptional activation.

Takeaway

MOZ-TIF2 is a protein that can stop other proteins from doing their job in cells, which might help explain why some leukemia patients don't respond well to treatment.

Methodology

The study used luciferase reporter systems to measure transcriptional activity in various cell lines after expressing the MOZ-TIF2 fusion protein.

Potential Biases

Potential bias in the interpretation of results due to reliance on specific cell lines and experimental conditions.

Limitations

The study primarily focused on in vitro systems, which may not fully replicate in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-4598-6-51

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication